IP Library Granted Patent US 9,085,797
Granted Patent B2
US 9,085,797 · App. 13/964,036 · Granted Jul 21, 2015

Method for deblocking of labeled oligonucleotides

Inventors: Gulilat Gebeyehu (Potomac, MD); Richard Pires (Mount Airy, MD)
Assignee: Life Technologies Corporation
C12Q1/68C07H21/00C07B2200/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,085,797
App. No.
13/964,036
Granted
Jul 21, 2015
Kind
B2
Abstract

The invention relates to a process for deblocking substantially a blocked, detectably labeled oligonucleotide by contacting the blocked detectably labeled oligonucleotide with an effective amount of a nucleophilic amino compound under conditions that result in substantial deblocking of the oligonucleotide, thereby giving the substantially deblocked oligonucleotide.

Claims (20)

1. A process for deblocking substantially a blocked, detectably labeled oligonucleotide comprising contacting the blocked detectably labeled oligonucleotide with an effective amount of a nucleophilic amino compound under conditions that result in the deblocking of the oligonucleotide, thereby giving the substantially deblocked oligonucleotide.

2. The process of claim 1 , wherein said detectable label is a fluorescent label.

3. The process of claim 2 , wherein said detectable label is hexachlorofluorescein.

4. The process of claim 2 , wherein said detectable label is DABCYL.

5. The process of claim 1 , wherein said nucleophilic amino compound is ammonia.

6. The process of claim 5 , wherein said ammonia is present at a psi of about 20 to 200.

7. The process of claim 5 , wherein said ammonia is present at a psi of about 80.

8. The process of claim 1 , wherein said nucleophilic amino compound is ammonia vapors.

9. The process of claim 1 , wherein said nucleophilic amino compound is a C 1-6 alkylamine.

10. The process of claim 1 , further comprising dissolving the substantially deblocked oligonucleotide in a buffer.

11. The process of claim 1 , wherein said conditions comprise carrying the process at about room temperature to about 150° C.

12. The process of claim 1 , wherein said conditions comprise carrying the process at about 95° C.

13. The process of claim 1 , further comprising wherein said substantially blocked, detectably labeled oligonucleotide is immobilized on a solid phase.

14. The process of claim 13 , further comprising wherein said substantially deblocked oligonucleotide is released from said solid phase under said conditions.

15. A process for deblocking substantially a blocked, detectably labeled oligonucleotide comprising contacting the blocked detectably labeled oligonucleotide with an effective amount of ammonia saturated with water vapor at about 80 psi, 95° C. for about 45 min, thereby giving the substantially deblocked oligonucleotide.

16. The process of claim 15 , further comprising wherein said blocked, detectably labeled oligonucleotide is immobilized on a solid phase.

17. The process of claim 16 , further comprising wherein said substantially deblocked oligonucleotide is released from said solid phase.

18. A composition comprising a blocked, detectably labeled oligonucleotide and an effective amount of a nucleophilic amino compound sufficient to deblock substantially said oligonucleotide.

19. The composition of claim 18 , wherein said detectable label is a fluorescent label.

20. The composition of claim 18 , wherein said nucleophilic amino compound is ammonia.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2013
From: GEBEYEHU, GULILAT; PIRES, RICHARD
To: LIFE TECHNOLOGIES, INC.
Reel/Frame 031019/0549 →
MERGER Recorded Aug 15, 2013
From: LIFE TECHNOLOGIES, INC.
To: INVITROGEN CORPORATION
Reel/Frame 031019/0659 →
MERGER Recorded Aug 15, 2013
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031019/0792 →
Continuity (5)
Continuation 13152907 · Jun 3, 2011
Continuation 10365644 · Feb 13, 2003
Continuation 09576555 · May 24, 2000
Provisional Application 60135848 · May 24, 1999
Related Publication 20140066612A1 · Mar 6, 2014